查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922993

专利卵圆孔闭合装置市场（按装置类型、给药方法、材质、最终用户和分销管道划分）－2026-2032年全球预测

Patent Foramen Ovale Closure Device Market by Device Type, Delivery Mode, Material, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年卵圆孔闭合装置市值为 9.1881 亿美元，预计到 2026 年将成长至 9.9244 亿美元，到 2032 年预计将达到 15.8575 亿美元，复合年增长率为 8.10%。

关键市场统计数据
基准年 2025 9.1881亿美元
预计年份：2026年 9.9244亿美元
预测年份 2032 15.8575亿美元
复合年增长率 (%) 8.10%

本文重点概述了不断发展的介入性心臟病学生态系统，该生态系统影响房间隔封堵术的器械研发、临床应用和采购趋势。

专利的卵圆孔封堵器市场处于介入性心臟病学、器材工程和医疗系统经济学的交汇点，将临床医生、製造商和支付方汇聚在一个复杂的创新生态系统中。本执行摘要概述了房间隔封堵解决方案的演变现状，重点介绍了关键驱动因素，包括手术偏好的变化、材料科学的进步以及对长期安全性和患者报告结果的日益关注。它还探讨了设计选择、交付流程和终端用户环境将如何影响现有和新兴供应商的采用趋势和竞争策略。

临床实务趋势、材料创新和医疗保健领域动态的融合如何重塑医疗器材设计重点、应用路径和商业策略

近年来，临床实践、器材工程和医疗服务模式的融合推动了卵圆孔未闭封堵通畅性领域的变革，并重新定义了该领域。微创技术的成熟使得经皮介入治疗备受关注，操作者的熟练程度和导管检查室的高效运作有助于缩短住院时间并加快患者康復。同时，设计创新也着重于更小巧的输送系统和更方便的取出方式，以满足临床医师对术中操作柔软性和病人安全性的需求。

美国近期加征关税对营运和采购产生了连锁反应，推动了供应链本地化、合约审查以及对医疗保健总成本的重新关注。

2025年，美国关税政策对医疗设备供应链、商业策略和采购计画产生了显着影响，促使製造商和医疗系统重新评估采购和定价策略。关税调整凸显了在地化生产、供应商多元化和库存优化的重要性，因为企业都在寻求降低采购成本波动并保持竞争力。这些营运调整往往会引发一些长期决策，例如生产地点的选择、哪些零件需要自主生产，以及如何建构分销协议以保障利润率和供应稳定性。

针对特定细分市场的产品设计、临床应用和商业性推广的影响因素，可以从医疗设备类型、给药方式、材料选择、临床环境和分销管道等方面来衡量。

细分市场层面的趋势揭示了不同的机会和风险特征，这些特征应指导产品开发和市场推广计划。这适用于器械类型、给药方式、材料、终端用户环境和分销策略。不同器械类型的考虑因素显示了不同的部署路径。室间隔封堵器强调易于部署和长期组织整合，而缝合系统则优先考虑非侵入性封堵以及在特定解剖情况下的潜在优势。同时，给药方式的差异仍具有重要影响。经皮途径通常与导管检查室的工作流程和操作者培训计划相符，而外科手术对于混合手术和需要直视及同期手术的高度复杂病例仍然至关重要。

美洲、欧洲、中东、非洲和亚太地区的区域差异会影响产品的采用路径、监管协调和商业化策略。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的监管路径、临床应用和商业策略产生了显着影响，每个地区都呈现出不同的机会环境和营运考量。在美洲，先进的介入性心臟病学网路和集中式卓越中心正在推动器械改进的快速普及，这些改进显着降低了手术复杂性并提高了患者周转率。医保报销环境和私立医院的采购流程也对哪些创新最终能够进入常规临床实践起着至关重要的作用。

透过整合服务模式实现竞争差异化，该模式支持临床证据、设备人体工学、实施支援和与临床医生建立长期伙伴关係。

老牌製造商与新参与企业之间的竞争主要集中在实证医学证据的累积、与临床医生的合作以及供应链的卓越性。主要企业正大力投资稳健的临床项目，以检验产品的安全性和长期疗效，同时改善器械的人体工学设计和输送系统，以减少术中併发症。与大型临床中心建立策略联盟以及参与註册研究是加速累积真实世界证据并有助于与支付方进行报销谈判的常用策略。

为设备製造商和医疗保健系统制定明确且优先的行动方案，以加强房间隔封堵术市场的临床可靠性、供应链韧性和商业性灵活性。

行业领导者应优先采取一系列行动，以在不断变化的临床和商业性环境中保持永续的竞争优势。首先，投资于有针对性的临床证据项目，检验长期安全性、功能性结果以及与其他封锁策略的比较性能，以消除支付方的疑虑并支持指南的发布。其次，优先改进器械，例如提高输送性、缩短手术时间和提高回收率，以应对临床医生面临的挑战，并在以导管为中心的医疗环境中加速器械的普及应用。

一个透明的混合方法研究框架，结合临床医生访谈、监管审查和比较分析，以得出检验的研究结果和背景限制因素。

本执行摘要的研究采用了混合方法，整合了定性访谈、文献综述和监管比较分析，从而对器械、临床和商业性趋势进行了多角度的观点。一级资讯来源包括与介入性心臟病专家、医院采购人员、临床试验研究人员和分销合作伙伴的结构化访谈，旨在了解实际操作中的偏好、培训需求和采购考虑。二级资讯来源包括同侪审查的临床文献、监管指导文件以及已发布的植入式医疗设备安全和报告标准。

关键策略要务的整合表明，临床证据、强大的业务运作和有针对性的商业化将决定产品的长期应用和市场定位。

总之，卵圆孔未闭封堵术这一专利器材领域正处于一个十字路口，临床创新、材料科学、商业策略和监管管理正在交汇融合，共同塑造其未来发展轨迹。关键驱动因素包括手术操作简单、可证实的长期治疗效果、供应链的适应性以及能够反映总治疗成本的商业模式。那些能够将产品开发与临床医生需求相结合、投资于有意义的真实世界数据并建立稳健的生产和分销基础设施的相关人员，将最有利于获得持续的价值。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依器械类型分類的专利卵圆孔闭合装置市场

  • 心房中隔封堵器
  • 缝合线输送系统

9. 依给药途径分類的卵圆孔闭合专利装置市场

  • 经皮
  • 外科

第十章 依材质分類的专利卵圆孔闭合装置市场

  • 镍钛诺
  • 聚合物

第十一章 依最终用户分類的专利卵圆孔闭合装置市场

  • 门诊手术中心
  • 心臟诊所
  • 医院
    • 私立医院
    • 公立医院

第十二章 专利卵圆孔闭合装置市场（依分销管道划分）

  • 离线
  • 在线的

第十三章 各地区专利卵圆孔闭合装置市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的专利卵圆孔闭合装置市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国专利卵圆孔闭合装置市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国专利卵圆孔闭合装置市场

第十七章 中国专利卵圆孔闭合装置市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Artech Medical
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Cardiovascular Systems, Inc.
  • Coherex Medical, Inc.
  • Cook Medical LLC
  • Medtronic plc
  • Neovasc Inc.
  • NMT Medical, Inc.
  • Occlutech International AG
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Shanghai Mallow Medical Instrument Co., Ltd.
  • Starway Medical Technology Inc.
  • Surmodics, Inc.
  • Vascular Innovations Co., Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-867BED9A9EAC

The Patent Foramen Ovale Closure Device Market was valued at USD 918.81 million in 2025 and is projected to grow to USD 992.44 million in 2026, with a CAGR of 8.10%, reaching USD 1,585.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 918.81 million
Estimated Year [2026] USD 992.44 million
Forecast Year [2032] USD 1,585.75 million
CAGR (%) 8.10%

A focused overview of the evolving interventional cardiology ecosystem shaping device development, clinical adoption, and procurement dynamics in septal closure therapies

The patent foramen ovale closure device landscape sits at the intersection of interventional cardiology, device engineering, and health system economics, bringing together clinicians, manufacturers, and payers in a complex innovation ecosystem. This executive summary introduces the contemporary context in which septal closure solutions are evolving, highlighting key drivers such as procedural preference shifts, material science advancements, and increasing attention to longitudinal safety and patient-reported outcomes. It frames the conversation around how design choices, delivery workflows, and end-user settings influence adoption and the competitive calculus for incumbent and emerging suppliers.

Clinical decision-making increasingly balances minimally invasive approaches against institutional capabilities and clinician experience. Concurrently, regulatory scrutiny and post-market surveillance demand robust evidence of durability and biocompatibility. As a result, development roadmaps are emphasizing both iterative improvements to device profiles and novel delivery concepts that reduce procedural complexity. Beyond technical considerations, stakeholders must engage with payer frameworks and reimbursement nuances that shape hospital procurement and ambulatory center uptake. The following sections expand on transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitor positioning, actionable recommendations, and the methodological basis for our findings to provide a coherent narrative for strategic planning and operational execution.

How converging clinical practice trends, material innovations, and site-of-care dynamics are reshaping device design priorities, adoption pathways, and commercial strategies

Recent years have produced transformative shifts that are redefining the patent foramen ovale closure landscape, driven by converging forces in clinical practice, device engineering, and healthcare delivery models. Minimally invasive techniques have matured, prompting greater interest in percutaneous approaches where operator familiarity and catheterization laboratory workflows support reduced hospital stays and accelerated recovery. At the same time, design innovation has emphasized reduced profile delivery systems and enhanced retrievability to address clinician preferences for intra-procedural flexibility and improved patient safety.

Material science progress, particularly with superelastic alloys and polymer coatings, has improved device conformability and tissue integration, which in turn shapes regulatory expectations and post-market evidence generation. Parallel to technical evolution, value-based care initiatives are influencing site-of-care decisions, with ambulatory surgical centers and outpatient-focused cardiac clinics increasingly evaluated for procedural suitability. Supply chain resilience and channel diversification have become priorities for manufacturers, leading to expanded distributor relationships and digital sales pathways. Collectively, these shifts have created an environment in which iterative clinical evidence, user-centered design, and adaptive commercialization strategies determine competitive differentiation and long-term market relevance.

The cascading operational and procurement consequences of recent U.S. tariff measures prompting supply chain localization, contracting revisions, and renewed focus on total cost of care

In 2025, tariff policies introduced by the United States have had measurable implications across medical device supply chains, commercial strategies, and procurement planning, prompting manufacturers and health systems to reassess sourcing and pricing approaches. Tariff adjustments have amplified the importance of localized manufacturing, supplier diversification, and inventory optimization as firms seek to mitigate input cost volatility and preserve competitive positioning. These operational shifts often translate into longer-term decisions about where to locate production, which components to insource, and how to structure distribution agreements to protect margins and supply reliability.

For health systems and purchasing teams, tariff-related cost pressures have reinforced scrutiny of total procedure costs and prompted renewed negotiations with vendors around bundled pricing, consignment models, and performance-based payment structures. At the same time, companies are accelerating efforts to demonstrate value beyond unit pricing by emphasizing procedure efficiency, reduced complication rates, and shorter length-of-stay metrics. Regulatory and customs complexities introduced by tariff regimes have also highlighted the need for transparent documentation, robust supplier qualification processes, and scenario planning to ensure continuity of care. Taken together, these dynamics are catalysing a strategic rebalancing of global sourcing, commercial contracting, and risk management practices across the sector.

Segment-specific implications for product design, clinical deployment, and commercial engagement framed across device types, delivery approaches, material choices, care settings, and distribution channels

Segment-level dynamics reveal differentiated opportunity and risk profiles that should shape product development and go-to-market plans across device types, delivery modes, materials, end-user settings, and distribution strategies. Considerations by device type illustrate divergent pathways: septal occluders emphasize ease of deployment and chronic tissue integration, while suture mediated systems prioritize atraumatic closure and potential advantages in specific anatomical scenarios. In parallel, delivery mode distinctions remain influential; percutaneous approaches are typically aligned with catheterization lab workflows and operator training programs, whereas surgical delivery retains relevance in hybrid or high-complexity cases where direct visualization or concomitant procedures are required.

Material selection continues to be a primary design lever, with nitinol offerings valued for superelasticity and predictable conformability and polymer variants explored for reduced imaging artifact and tailored bioresorption profiles. End-user segmentation highlights how ambulatory surgical centers demand streamlined device profiles and rapid turnover amenability, cardiac clinics focus on procedural throughput and ambulatory follow-up capabilities, and hospitals-both private and public-assess devices within broader procurement frameworks that consider training, inventory, and post-market surveillance responsibilities. Finally, distribution strategy nuances matter: direct sales relationships enable deep clinical engagement and training, distributors provide reach and logistics optimization, and online channels support access to consumables and information; together these channels shape market access models and customer experience across the care continuum.

How regional variations across the Americas, Europe Middle East and Africa, and Asia-Pacific influence adoption pathways, regulatory alignment, and commercialization strategies

Regional dynamics significantly influence regulatory pathways, clinical adoption, and commercial strategies across the Americas, Europe Middle East and Africa, and Asia-Pacific, each presenting distinct opportunity landscapes and operational considerations. In the Americas, sophisticated interventional cardiology networks and concentrated centers of excellence support rapid uptake of device iterations that demonstrably reduce procedure complexity and improve patient throughput. Reimbursement environments and private hospital procurement processes also play a central role in shaping which innovations clear pathways into routine practice.

Across Europe, the Middle East and Africa, regulatory harmonization efforts, varying payer structures, and heterogenous hospital infrastructure lead manufacturers to pursue adaptive market entry strategies that prioritize evidence generation aligned to national health technology assessment requirements and strategic partnerships with local distributors and clinical champions. The Asia-Pacific region often combines high-volume procedural demand with diverse regulatory regimes, presenting both scale potential and the need for localized value propositions, supply chain agility, and culturally adapted clinical training programs. In all regions, a clear understanding of site-of-care preferences, referral patterns, and clinician network influence is critical to crafting differentiated commercialization plans and ensuring sustainable uptake over time.

Competitive differentiation driven by clinical evidence, device ergonomics, and integrated service models that support adoption and long-term clinician partnerships

Competitive positioning among established manufacturers and newer entrants centers on evidence generation, clinician engagement, and supply chain excellence. Leading companies are investing in robust clinical programs to validate safety and long-term outcomes while refining device ergonomics and delivery systems to reduce intra-procedural complexity. Strategic partnerships with high-volume clinical centers and participation in registry initiatives are common tactics to accelerate real-world evidence accumulation and to support reimbursement discussions with payers.

Smaller innovators frequently pursue niche strategies by addressing specific anatomical challenges or by introducing materials and coatings that target improved tissue integration or reduced imaging artifact. These companies may leverage distributor networks or digital engagement platforms to amplify reach while managing capital intensity. Across the competitive field, differentiation increasingly depends on the ability to provide training, simulation, and post-market support, as purchasers weigh not only device performance but also the total service package that governs procedural success and patient outcomes. As a result, successful market players combine clinical credibility, operational reliability, and transparent commercial terms to build durable relationships with healthcare providers.

Clear and prioritized actions for device makers and health systems to strengthen clinical credibility, supply chain resilience, and commercial agility in septal closure markets

Industry leaders should pursue a set of prioritized actions to maintain relevance and capture sustainable advantage amid evolving clinical and commercial dynamics. First, invest in targeted clinical evidence programs that address long-term safety, functional outcomes, and comparative performance versus alternative closure strategies to reduce payer friction and support guideline inclusion. Second, prioritize iterative device improvements that enhance deliverability, reduce procedural time, and improve retrievability, thereby addressing clinician pain points and accelerating adoption in catheter-centric settings.

Third, develop flexible manufacturing and sourcing strategies to mitigate tariff and supply chain risks, including options for localized production or qualified alternative suppliers to preserve continuity and margin discipline. Fourth, cultivate multi-channel commercial models that balance the depth of direct clinical engagement with the breadth of distributor and digital channels, enabling scalable training, remote support, and inventory management. Fifth, align with health system priorities by articulating total cost of care advantages and offering outcome-linked contracting models where appropriate. By executing these actions with disciplined project management and clinician co-creation, organizations can convert current disruptions into durable competitive capabilities.

A transparent mixed-methods research framework combining clinician interviews, regulatory review, and comparative analysis to produce validated insights and contextual limitations

The research underpinning this executive summary was constructed using a mixed-methods approach that integrated primary qualitative interviews, secondary literature review, and comparative regulatory analysis to create a multidimensional perspective on device, clinical, and commercial dynamics. Primary inputs included structured discussions with interventional cardiologists, hospital procurement leaders, clinical trial investigators, and distribution partners to surface real-world procedural preferences, training needs, and procurement considerations. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, and published standards governing implantable device safety and reporting.

Analytical procedures employed cross-validation techniques to reconcile divergent perspectives and to ensure internal consistency among clinical claims, engineering trade-offs, and commercial behaviours. Geographic comparisons relied on country-level regulatory frameworks and health system typologies to contextualize regional differences. Throughout the process, attention was paid to data provenance, transparency of assumptions, and the limitations inherent to publicly available information and interview sampling. This methodological rigor supports the credibility of the insights while acknowledging areas where further targeted data collection-such as longitudinal registries or payer-specific economic analyses-would strengthen decision-making.

Synthesis of critical strategic imperatives showing how clinical evidence, resilient operations, and targeted commercialization will determine long-term adoption and positioning

In conclusion, the patent foramen ovale closure device field stands at a juncture where clinical innovation, material science, commercial strategy, and regulatory stewardship converge to shape future trajectories. Key drivers include procedural simplification, demonstrable long-term outcomes, supply chain adaptability, and commercial models that reflect total cost of care. Stakeholders that align product development with clinician needs, invest in meaningful real-world evidence, and design resilient manufacturing and distribution footprints will be best positioned to capture durable value.

Looking forward, the interplay between regional regulatory environments, site-of-care trends, and evolving payer expectations will continue to influence which device attributes become decisive. Early and sustained engagement with clinical champions, thoughtful segmentation-based commercialization, and proactive risk mitigation against tariff and logistics disruption are prudent. Ultimately, the capacity to convert technical advantages into measurable clinical and economic outcomes will determine market leadership and sustained adoption across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patent Foramen Ovale Closure Device Market, by Device Type

  • 8.1. Septal Occluder
  • 8.2. Suture Mediated System

9. Patent Foramen Ovale Closure Device Market, by Delivery Mode

  • 9.1. Percutaneous
  • 9.2. Surgical

10. Patent Foramen Ovale Closure Device Market, by Material

  • 10.1. Nitinol
  • 10.2. Polymer

11. Patent Foramen Ovale Closure Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Clinics
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals

12. Patent Foramen Ovale Closure Device Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Patent Foramen Ovale Closure Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Patent Foramen Ovale Closure Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Patent Foramen Ovale Closure Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Patent Foramen Ovale Closure Device Market

17. China Patent Foramen Ovale Closure Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artech Medical
  • 18.7. Biotronik SE & Co. KG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardia, Inc.
  • 18.10. Cardiovascular Systems, Inc.
  • 18.11. Coherex Medical, Inc.
  • 18.12. Cook Medical LLC
  • 18.13. Medtronic plc
  • 18.14. Neovasc Inc.
  • 18.15. NMT Medical, Inc.
  • 18.16. Occlutech International AG
  • 18.17. Sahajanand Medical Technologies Pvt. Ltd.
  • 18.18. Shanghai Mallow Medical Instrument Co., Ltd.
  • 18.19. Starway Medical Technology Inc.
  • 18.20. Surmodics, Inc.
  • 18.21. Vascular Innovations Co., Ltd.
  • 18.22. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SEPTAL OCCLUDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUTURE MEDIATED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. GCC PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. G7 PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 143. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. NATO PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA PATENT FORAMEN OVALE CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)